According to a report by Reports and Data, the global market for Immune BCG is expected to reach USD 73.02 million by 2028, with a compound annual growth rate (CAGR) of 4.5% during the forecast period. The report attributes the growth in the Immune BCG market to increasing demand for the vaccine to combat tuberculosis, rising emphasis on immunization in emerging economies, and technological...